# Amentum Holdings, Inc. (AMTM) · Edgar & Edgarette company card

> Amentum Holdings (AMTM) grew revenue 71.6% in FY2025 to $14.4 billion, operating margin 3.3% against a 7.9% median for business services, equity 39.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 2011286 · fiscal year ended 2025-10-03 · 4 audited years read · [page](https://www.pops4.com/boards/company/AMTM) · [JSON](https://www.pops4.com/boards/company/AMTM.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $14.4B |
| Revenue growth, 1 year | 71.6% |
| Revenue growth per year | 23.2% |
| Operating margin | 3.3% (prior year 3.5%) |
| Net margin | 0.5% |
| Operating cash flow | $543M |
| Capital spending | $27M |
| Free cash flow | $516M |
| Cash | $437M |
| Long-term debt | $3.9B |
| Total assets | $11.5B |
| Total equity | $4.5B |
| Equity ÷ assets | 39.3% |
| Return on equity | 1.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 1.28 (grey zone)
- Piotroski F: 7 of 9 (solid)
- Health Harbor boat: Sound ship · one warning sign · revenue is hard to predict: its 80% range is ±25%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $14.4B (FY2025), total debt $3.9B. Experience: revenue up 71.6% on the year, up 23.2% a year over 3 years; operating margin 3.3%, down from 3.5%. Soundness: equity 39.3% of assets, return on equity 1.5%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $15.8B and $26.3B next year (method v4.1: its own 3-year record of growth weighed at 40% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $12.6B to $32.3B. A statistical range, not company guidance. Against peers (70 filers, $50M+ revenue, services-business services, nec): operating margin 3.3% against a 7.9% median; growth 71.6% against 10.2%.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 1, latest 2026-10-02 ([filing](https://www.sec.gov/Archives/edgar/data/2011286/000201128626000026/0002011286-26-000026-index.htm))

## Recent filings

- 8-K · filed 2026-10-02 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2011286/000201128626000026/0002011286-26-000026-index.htm)
- 10-Q · filed 2026-08-11 · [filing](https://www.sec.gov/Archives/edgar/data/2011286/000162828026055727/0001628280-26-055727-index.htm)
- 8-K · filed 2026-08-10 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2011286/000162828026055294/0001628280-26-055294-index.htm)
- 10-Q · filed 2026-05-12 · [filing](https://www.sec.gov/Archives/edgar/data/2011286/000162828026034156/0001628280-26-034156-index.htm)
- 8-K · filed 2026-05-11 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2011286/000162828026033648/0001628280-26-033648-index.htm)
- 8-K · filed 2026-04-28 · 1.01 Entry into a Material Definitive Agreement · [filing](https://www.sec.gov/Archives/edgar/data/2011286/000201128626000011/0002011286-26-000011-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0002011286.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2011286

## Cite

POPS4, Edgar & Edgarette: Amentum Holdings, Inc. (AMTM) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/AMTM. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

